Medable

Medable

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.medable.com

Last Round

Series D

10/26/2021

Est. Valuation

$2.1B

Total Funding Raised

$481.6M

Company Overview

Medable is a healthcare technology company that offers a cloud-based platform to deliver effective therapies to patients, featuring modules for back-end operations, analytics, collaboration, compliance, and research surveys, all designed to address the sector's stringent compliance, interoperability, and privacy requirements while facilitating streamlined digital trials and broad patient access.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Patient Engagement, Telemedicine, Low-Code/No-Code

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

decentralized clinical trialsDCT platformclinical trial softwarehybrid clinical trialsvirtual trialspatient-centric trialseCOAeConsentelectronic clinical outcome assessmentclinical trial techagentic AI platformpharma techAI agentclinical trial automationCRO softwareno-code platformTMF automationTrial Master File automationcell & gene therapy trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medable Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Medable Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D10/26/2021
Series C Extension4/15/2021
Series C11/19/2020
VC Round5/4/2020
Series B2/1/2017
Seed
12/4/2015

Key People

Founding team and executive leadership

Tim Smith

Co-Founder, CTO

Founding Team

Jon McClelland

Chief Product Officer

Executive Team

Medable Investors

Notable investors and investment history

InvestorRounds
Launchpad Digital HealthSeed
HealthX VenturesSeries B
Streamlined VenturesSeries C, Series C Extension
GSR VenturesSeries C, Series C Extension, Series D, VC Round
Obvious VenturesSeries C Extension
Blackstone GrowthSeries D
Sapphire VenturesSeries D, Series C, Series C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    Launched an AI Agent to streamline Trial Master File processes.

  • Sep 17, 2025

    Named a Leader in Everest Group's 2025 eCOA Products PEAK Matrix.

Medable Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medable Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medable's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range335
Year Founded2012
Last Funding10/26/2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.